Clinical Trial

Risk-Stratified Hypofractionated Radiotherapy After Breast-Conserving Surgery for Early Breast Cancer

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This prospective study is designed to evaluate the feasibility, efficacy, and safety of risk-stratified hypofractionated radiotherapy after breast-conserving surgery in patients with early breast cancer.
Trial Details
NCT Number NCT07657442
Lead Sponsor Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Conditions Early Stage Breast Carcinoma, Breast Cancer
Enrollment 649 participants
Start Date 2026-06-15
Primary Completion 2027-12-31 (estimated)
Study Completion 2032-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-18